These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 13601868)
41. [Coenzyme pool and the functional status of erythrocytes in patients during sorption detoxication]. Spas VV; Trebukhina RV; Petushok VG; Mikhal'tsevich GN; Lashak LK Anesteziol Reanimatol; 1988; (2):50-2. PubMed ID: 3408003 [No Abstract] [Full Text] [Related]
42. The antimalarial action of primaquine against the blood and tissue stages of falciparum malaria (Panama, P-F-6 strain). ARNOLD J; ALVING AS; HOCKWALD RS; CLAYMAN CB; DERN RJ; BEUTLER E; FLANAGAN CL; JEFFERY GM J Lab Clin Med; 1955 Sep; 46(3):391-7. PubMed ID: 13252317 [No Abstract] [Full Text] [Related]
43. Synthesis, characterization, and cellular localization of a fluorescent probe of the antimalarial 8-aminoquinoline primaquine. McQueen A; Blake LD; Azhari A; Kemp MT; McGaha TW; Namelikonda N; Larsen RW; Manetsch R; Kyle DE Bioorg Med Chem Lett; 2017 Oct; 27(20):4597-4600. PubMed ID: 28939120 [TBL] [Abstract][Full Text] [Related]
44. [Nucleotides, coenzymes and indirect glycolysis metabolites in neonate's erythrocytes in a case of chromosome 18 trisomy (Edward's syndrome)]. Wójcicka J; Roszkowski I Ginekol Pol; 1975 Jan; 46(1):73-81. PubMed ID: 1110031 [No Abstract] [Full Text] [Related]
45. Primaquine-induced hemolytic anemia: role of membrane lipid peroxidation and cytoskeletal protein alterations in the hemotoxicity of 5-hydroxyprimaquine. Bowman ZS; Morrow JD; Jollow DJ; McMillan DC J Pharmacol Exp Ther; 2005 Aug; 314(2):838-45. PubMed ID: 15840764 [TBL] [Abstract][Full Text] [Related]
46. Pathway-specific inhibition of primaquine metabolism by chloroquine/quinine. Fasinu PS; Tekwani BL; Avula B; Chaurasiya ND; Nanayakkara NP; Wang YH; Khan IA; Walker LA Malar J; 2016 Sep; 15(1):466. PubMed ID: 27618912 [TBL] [Abstract][Full Text] [Related]
48. GENERATION OF HYDROGEN PEROXIDE IN ERYTHROCYTES BY HEMOLYTIC AGENTS. COHEN G; HOCHSTEIN P Biochemistry; 1964 Jul; 3():895-900. PubMed ID: 14214074 [No Abstract] [Full Text] [Related]
49. Modifications of primaquine as antimalarials. 4. 5-Alkoxy derivatives of primaquine. Chen EH; Tanabe K; Saggiomo AJ; Nodiff EA J Med Chem; 1987 Jul; 30(7):1193-9. PubMed ID: 3599024 [TBL] [Abstract][Full Text] [Related]
50. The hemolytic effect of primaquine and related compounds: a review. BEUTLER E Blood; 1959 Feb; 14(2):103-39. PubMed ID: 13618370 [No Abstract] [Full Text] [Related]
51. An automated method of mass drug testing applied to screening for antimalarial activity. Cenedella RJ; Saxe LH; Van Dyke K Chemotherapy; 1970 Mar; 15(3):158-76. PubMed ID: 5428024 [No Abstract] [Full Text] [Related]
52. Initial stages in the biosynthesis of porphyrins. 2. The formation of delta-aminolaevulic acid from glycine and succinyl-coenzyme A by particles from chicken erythrocytes. GIBSON KD; LAVER WG; NEUBERGER A Biochem J; 1958 Sep; 70(1):71-81. PubMed ID: 13584304 [No Abstract] [Full Text] [Related]
53. IN VIVO GENERATION OF H2O2 IN MOUSE ERYTHROCYTES BY HEMOLYTIC AGENTS. COHEN G; HOCHSTEIN P J Pharmacol Exp Ther; 1965 Jan; 147():139-43. PubMed ID: 14255158 [No Abstract] [Full Text] [Related]
54. [Chemotherapy of experimental Chagas' disease. XII. Effects of puromycin alone and with primaquine]. PIZZI T; PRAGER R; KNIERIM F Bol Inf Parasit Chil; 1953; 8(4):77-9. PubMed ID: 13140423 [No Abstract] [Full Text] [Related]
55. Antimalarial activity and inhibition of monoamine oxidases A and B by exo-erythrocytic antimalarials. Optical isomers of primaquine, N-acylated congeners, primaquine metabolites and 5-phenoxy-substituted analogues. Brossi A; Millet P; Landau I; Bembenek ME; Abell CW FEBS Lett; 1987 Apr; 214(2):291-4. PubMed ID: 3569526 [TBL] [Abstract][Full Text] [Related]
56. Hemolytic effect of therapeutic drugs. Clinical considerations of the primaquine-type hemolysis. KELLERMEYER RW; TARLOV AR; BREWER GJ; CARSON PE; ALVING AS JAMA; 1962 May; 180():388-94. PubMed ID: 14454972 [No Abstract] [Full Text] [Related]
57. Anti-tumoral activity of imidazoquines, a new class of antimalarials derived from primaquine. Fernandes I; Vale N; de Freitas V; Moreira R; Mateus N; Gomes P Bioorg Med Chem Lett; 2009 Dec; 19(24):6914-7. PubMed ID: 19896373 [TBL] [Abstract][Full Text] [Related]
58. Effects of novel triple-stage antimalarial ionic liquids on lipid membrane models. Ferraz R; Pinheiro M; Gomes A; Teixeira C; Prudêncio C; Reis S; Gomes P Bioorg Med Chem Lett; 2017 Sep; 27(17):4190-4193. PubMed ID: 28733082 [TBL] [Abstract][Full Text] [Related]
59. The hemolytic effect of primaquine. XV. Role of methemoglobin. BREWER GJ; TARLOV AR; KELLERMEYER RW; ALVING AS J Lab Clin Med; 1962 Jun; 59():905-17. PubMed ID: 13872969 [No Abstract] [Full Text] [Related]
60. AN EVALUATION OF ANTIMALARIAL COMBINATIONS AGAINST PLASMODIUM BERGHEI IN THE MOUSE. JACOBS RL; ALLING DW; CANTRELL WF J Parasitol; 1963 Dec; 49():920-5. PubMed ID: 14084196 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]